SYGNIS AG: SYGNIS AG to attend upcoming Investor Conferences
(firmenpresse) - (DGAP-Media / 07.11.2013 / 09:29)
Press Release
SYGNIS AG to attend upcoming Investor Conferences
Madrid/Heidelberg, 7 November 2013 - SYGNIS AG (Frankfurt: LIO1; ISIN:
DE000A1RFM03; Prime Standard segment of the German Stock Exchange), the DNA
amplification and sequencing company, announced today the attendance at two
major German investor conferences in November and December 2013.
German Equity Forum hosted by Deutsche Börse AG
Date of Attendance: 12 and 13 November 2013
Venue: Frankfurt/Main, Germany, Congress Center
Attending and available for meetings: Pilar de la Huerta, CEO/CFO
More information: http://www.eigenkapitalforum.com/
16. Munich Capital Markets Conference hosted by GBC AG
Date of presentation: 04 December 2013, 15:10 - 15:50 pm CET
Venue: Munich, Germany, Sofitel Hotel, Room GBC III
Presentation at the MC Services HealthCare Forum and available for
meetings: Pilar de la Huerta, CEO/CFO
More information: http://www.mkk-investor.de/
If you like to meet us please contact for both conferences:
contact(at)mc-services.eu or via phone: +49 89 210 228-0.
For further information please contact:
SYGNIS AGAbout SYGNIS AG: www.sygnis.com
Pilar de la Huerta, CEO/CFO
Tel: +34-918063089
Email: pdelahuerta(at)sygnis.es
After the merger in 2012 between X-Pol Biotech, specialising in DNA
amplification and sequencing, and SYGNIS AG, listed in the German Stock
Exchange (Prime Standard segment, Tick: LIO1; ISIN: DE000A1RFM03), SYGNIS'
new mission is to develop and distribute technologies and products from
X-Pol, which has a commercial product in the DNA amplification segment,
QualiPhi(R) and is currently developing other products in the field of Next
Generation Sequencing.
### Disclaimer
This publication is intended for information only and constitutes neither
an offer to sell nor an invitation to buy securities. Some statements
included in this press release, relating neither to proven financial
results nor other historical data, should be viewed as forward-looking,
i.e. not definite. Such statements are mainly predictions of future
results, trends, plans or goals. These statements should not be considered
to be total guarantees since given their very nature they are subject to
known and unknown risks and imponderability and can be affected by other
factors as a consequence of which the actual results, plans and goals of
SYGNIS AG may deviate greatly from the established conclusions or implied
predictions contained in such statements. SYGNIS does not undertake to
publicly update or revise these statements in the light of new information
or future results or for any other reason.###
End of Media Release
---------------------------------------------------------------------
Issuer: SYGNIS AG
Key word(s): Research/Technology
07.11.2013 Dissemination of a Press Release, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: SYGNIS AG
Im Neuenheimer Feld 515
69120Heidelberg
Germany
Phone: 06221 454-6
Fax: 06221 454-700
E-mail: contact(at)sygnis.de
Internet: www.sygnis.de
ISIN: DE000A1RFM03
WKN: A1RFM0
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP-Media
---------------------------------------------------------------------
238479 07.11.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="Nanostruck Announces Delivery of Nanoclear Field Test Trial UnitsDatum: 07.11.2013 - 09:29 Uhr
Sprache: Deutsch
News-ID 313741
Anzahl Zeichen: 5263
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 263 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SYGNIS AG: SYGNIS AG to attend upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
SYGNIS AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
